The real-world safety of ticagrelor among older adults (above 75 years): a pharmacovigilance study from the FDA data

被引：0
|
作者：
Lerman, T. [1 ]
Yacoby, I [1 ]
Fishman, B. [2 ]
Goldman, A. [2 ]
Talmor-Barkan, Y. [1 ]
Itelman, E. [1 ]
Orvin, K. [1 ]
Eisen, A. [1 ]
Kornowski, R. [1 ]
Levi, A. [1 ]
机构：
[1] Rabin Med Ctr, Petah Tiqwa, Israel
[2] Sheba Med Ctr, Ramat Gan, Israel
来源：
EUROPEAN HEART JOURNAL | 2024年 / 45卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Safety of Antiplatelet Agents: Analysis of 'Real-World' Data from the Italian National Pharmacovigilance Network
    Gozzo, Lucia
    Navarria, Andrea
    Benfatto, Giuseppe
    Longo, Laura
    Mansueto, Silvana
    Sottosanti, Laura
    Pani, Luca
    Salomone, Salvatore
    Drago, Filippo
    CLINICAL DRUG INVESTIGATION, 2017, 37 (11) : 1067 - 1081
  • [22] Safety of Antiplatelet Agents: Analysis of ‘Real-World’ Data from the Italian National Pharmacovigilance Network
    Lucia Gozzo
    Andrea Navarria
    Giuseppe Benfatto
    Laura Longo
    Silvana Mansueto
    Laura Sottosanti
    Luca Pani
    Salvatore Salomone
    Filippo Drago
    Clinical Drug Investigation, 2017, 37 : 1067 - 1081
  • [23] Post-marketing safety of panitumumab: a real-world pharmacovigilance study
    Wen, Heli
    Lei, Yuqing
    Mao, Lingjie
    EXPERT OPINION ON DRUG SAFETY, 2024,
  • [24] Ginkgo biloba extract safety: Insights from a real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events
    Yao, Yinhui
    Zhao, Jingyi
    Li, Chen
    Chen, Yan
    Zhang, Tianci
    Dong, Xianhui
    Gao, Weijuan
    Shang, Yazhen
    JOURNAL OF ETHNOPHARMACOLOGY, 2025, 337
  • [25] A real-world pharmacovigilance study of FDA adverse event reporting system events for sildenafil
    Wang, Yan
    Zhao, Bin
    Yang, Haiyan
    Wan, Zheng
    ANDROLOGY, 2024, 12 (04) : 785 - 792
  • [26] A real-world pharmacovigilance study of FDA adverse event reporting system events for daratumumab
    Yun, Xiaolin
    Zhou, Yingying
    Wu, Danna
    Liu, Yuanbo
    Wu, Qiongshi
    EXPERT OPINION ON DRUG SAFETY, 2024, 23 (05) : 581 - 591
  • [27] A real-world pharmacovigilance study of FDA adverse event reporting system events for diazepam
    He, Weizhen
    Wang, Yang
    Chen, Kaiqin
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [28] A real-world pharmacovigilance study of FDA adverse event reporting system events for atogepant
    Wen, Heli
    Ding, Yitian
    Chen, Feichi
    EXPERT OPINION ON DRUG SAFETY, 2024,
  • [29] A Real-World Pharmacovigilance Study of FDA Adverse Event Reporting System (FAERS) for Mavacamten
    Yukselen, Zeynep
    Raju, Arvind Kumar Venkataramana
    Kumar, Pramukh Arun
    Ujjawal, Aditi
    Dasari, Mahati
    Parajuli, Shreyash
    Nakhla, Michael
    Bansal, Kannu
    Ganatra, Sarju
    Dani, Sourbha S.
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2024, 24 (06) : 791 - 799
  • [30] A real-world pharmacovigilance study of FDA adverse event reporting system events for Capmatinib
    Qi, Yiming
    Li, Jing
    Lin, Sisi
    Wu, Shuangshuang
    Chai, Kequn
    Jiang, Xin
    Qian, Jiancheng
    Jiang, Cheng
    SCIENTIFIC REPORTS, 2024, 14 (01):
12345